Effects of apolipoprotein A5 haplotypes on the ratio of triglyceride to high-density lipoprotein cholesterol and the risk for metabolic syndrome in Koreans

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Cha, Seongwon ^a   Yu, Hyunjoo ^a   Park, Ah Yeon ^a   Song, Kwang Hoon ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

APOA5; Haplotype; HDL cholesterol; Metabolic syndrome; Polymorphism; Triglceride to HDL cholesterol ratio; Triglyceride; ZNF259

Indexed keywords

APOLIPOPROTEIN A5; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZNF259 PROTEIN; ADENINE; CYTOSINE; GUANINE; THYMINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; HAPLOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; APOA5 GENE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; ETHNIC GROUP; GENE; GENE FREQUENCY; GENE LOCATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HETEROZYGOTE; KOREAN; PATHOPHYSIOLOGY; PREVALENCE; TRIACYLGLYCEROL BLOOD LEVEL; ZNF259 GENE;

ADULT; APOLIPOPROTEINS A; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 84898475808     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511x-13-45     Document Type: Article

References (33)

1. Association of Apolipoprotein A5 Gene -1131T>C Polymorphism with the Risk of Metabolic Syndrome in Korean Subjects. Song KH, Cha S, Yu SG, Yu H, Oh SA, Kang NS, Biomed Research International 2013 2013 585134 23509746
2. A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Kraja AT, Vaidya D, Pankow JS, Goodarzi MO, Assimes TL, Kullo IJ, Sovio U, Mathias RA, Sun YV, Franceschini N, Absher D, Li G, Zhang Q, Feitosa MF, Glazer NL, Haritunians T, Hartikainen AL, Knowles JW, North KE, Iribarren C, Kral B, Yanek L, O'Reilly PF, McCarthy MI, Jaquish C, Couper DJ, Chakravarti A, Psaty BM, Becker LC, Province MA, et al. Diabetes 2011 60 1329 1339 10.2337/db10-1011 21386085
3. Common variants at 30 loci contribute to polygenic dyslipidemia. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, et al. Nat Genet 2009 41 56 65 10.1038/ng.291 19060906
4. Genetic variants and the metabolic syndrome: a systematic review. Povel CM, Boer JM, Reiling E, Feskens EJ, Obes Rev 2011 12 952 967 10.1111/j.1467-789X.2011.00907.x 21749608
5. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC, Hum Mol Genet 2002 11 3031 3038 10.1093/hmg/11.24.3031 12417524 (Pubitemid 35414816)
6. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Olivier M, Wang X, Cole R, Gau B, Kim J, Rubin EM, Pennacchio LA, Genomics 2004 83 912 923 10.1016/j.ygeno.2003.11.016 15081120 (Pubitemid 38469930)
7. DNA polymorphisms and haplotypes of apolipoprotein A5's attribution to the plasma triglyceride levels in Koreans. Choi JR, Nam CM, Kang DR, Eom SM, Lee HJ, Park CM, Im JW, Jang Y, Yonsei Med J 2007 48 609 618 10.3349/ymj.2007.48.4. 609 17722232 (Pubitemid 47496722)
8. Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population. Chien KL, Chen MF, Hsu HC, Su TC, Chang WT, Lee CM, Lee YT, Clin Chim Acta 2008 388 78 83 10.1016/j.cca.2007.10.006 17964293 (Pubitemid 350266570)
9. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Matsunaga A, Arishima H, Niimura H, Zhang B, Uehara Y, Ohwaki K, Morita M, Hayashida K, Saku K, Circ J 2007 71 746 752 10.1253/circj.71.746 17457003 (Pubitemid 46683368)
10. APOA5 variants and metabolic syndrome in Caucasians. Grallert H, Sedlmeier EM, Huth C, Kolz M, Heid IM, Meisinger C, Herder C, Strassburger K, Gehringer A, Haak M, Giani G, Kronenberg F, Wichmann HE, Adamski J, Paulweber B, Illig T, Rathmann W, J Lipid Res 2007 48 2614 2621 10.1194/jlr.M700011-JLR200 17768309 (Pubitemid 350272846)
11. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome. Kisfali P, Mohas M, Maasz A, Polgar N, Hadarits F, Marko L, Brasnyo P, Horvatovich K, Oroszlan T, Bagosi Z, Bujtor Z, Gasztonyi B, Rinfel J, Wittmann I, Melegh B, Nutr Metab Cardiovasc Dis 2010 20 505 511 10.1016/j.numecd.2009.05.001 19692219
12. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Qi L, Liu S, Rifai N, Hunter D, Hu FB, Atherosclerosis 2007 192 204 210 10.1016/j.atherosclerosis.2006.05.006 16781717 (Pubitemid 46602299)
13. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM, Science 2001 294 169 173 10.1126/science.1064852 11588264 (Pubitemid 32952971)
14. The ins (cell) and outs (plasma) of apolipoprotein A-V. Forte TM, Shu X, Ryan RO, J Lipid Res 2009 50 Suppl 150 155 19050314
15. Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Galcheva-Gargova Z, Konstantinov KN, Wu IH, Klier FG, Barrett T, Davis RJ, Science 1996 272 1797 1802 10.1126/science.272.5269.1797 8650580 (Pubitemid 26256401)
16. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation. Kawakami A, Tanaka A, Chiba T, Nakajima K, Shimokado K, Yoshida M, Circulation 2003 108 2679 2688 10.1161/01.CIR.0000093278.75565.87 14623816 (Pubitemid 37466811)
17. Association between EGF and lipid concentrations: a benefit role in the atherosclerotic process? Berrahmoune H, Lamont JV, Herbeth B, Lambert D, Masson C, McPhillips M, Fitzgerald PS, Visvikis-Siest S, Clin Chim Acta 2009 402 196 198 10.1016/j.cca.2008.12.033 19167371
18. Different effects of apolipoprotein A5 SNPs and haplotypes on triglyceride concentration in three ethnic origins. Ken-Dror G, Goldbourt U, Dankner R, J Hum Genet 2010 55 300 307 10.1038/jhg.2010.27 20395964
19. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Holm H, Ding EL, Johnson T, Schunkert H, Samani NJ, Clarke R, Hopewell JC, Thompson JF, Li M, Thorleifsson G, Newton-Cheh C, Musunuru K, Pirruccello JP, Saleheen D, Chen L, Stewart AF, Schillert A, Thorsteinsdottir U, Thorgeirsson G, Anand S, Engert JC, Morgan T, Spertus J, et al. Lancet 2012 380 572 580 10.1016/S0140-6736(12)60312-2 22607825
20. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Assmann G, Schulte H, Am J Cardiol 1992 70 733 737 10.1016/0002-9149(92)90550-I 1519522
21. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE, Circulation 1997 96 2520 2525 10.1161/01.CIR.96.8.2520 9355888 (Pubitemid 27451340)
22. High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease. da Luz PL, Favarato D, Faria-Neto JR Jr, Lemos P, Chagas AC, Clinics (Sao Paulo) 2008 63 427 432 18719750
23. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D, Simon J, Krauss RM, Am J Cardiol 2005 96 399 404 10.1016/j.amjcard.2005.03.085 16054467 (Pubitemid 41058868)
24. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk. Salazar MR, Carbajal HA, Espeche WG, Dulbecco CA, Aizpurua M, Marillet AG, Echeverria RF, Reaven GM, Diab Vasc Dis Res 2011 8 109 116 10.1177/1479164111403170 21562062
25. Use of metabolic markers to identify overweight individuals who are insulin resistant. McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G, Ann Intern Med 2003 139 802 809 10.7326/0003-4819-139-10-200311180-00007 14623617
26. Bone mineral density-associated polymorphisms are associated with obesity-related traits in Korean adults in a sex-dependent manner. Cha S, Yu H, Kim JY, PLoS One 2012 7 53013 10.1371/journal.pone.0053013 23300848
27. Treatment of High Blood Cholesterol in A: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Expert Panel on Detection E, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
28. WHO/IASO/IOTF, The Asia-Pacific perspective: redefining obesity and its treatment Melbourne: Health Communications Australia 2000
29. SNP genotyping through the melting analysis of unlabelled oligonucleotide applied on dilute PCR amplicon. Jeong S, Yu H, Lee Y, Kim JY, J Biotechnol 2011 154 321 325 10.1016/j.jbiotec.2011.05.017 21679732
30. Genome-wide association analysis of Sasang constitution in the Korean population. Kim BY, Jin HJ, Kim JY, J Altern Complement Med 2012 18 262 269 10.1089/acm.2010.0764 22394158
31. Haploview: analysis and visualization of LD and haplotype maps. Barrett JC, Fry B, Maller J, Daly MJ, Bioinformatics 2005 21 263 265 10.1093/bioinformatics/bth457 15297300 (Pubitemid 40202029)
32. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Stephens M, Scheet P, Am J Hum Genet 2005 76 449 462 10.1086/428594 15700229 (Pubitemid 40250525)
33. A new statistical method for haplotype reconstruction from population data. Stephens M, Smith NJ, Donnelly P, Am J Hum Genet 2001 68 978 989 10.1086/319501 11254454 (Pubitemid 32289743)